FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

De Novo Granted to Sleeping Infant Device

[ Price : $8.95]

FDA grants a de novo marketing authorization to Happiest Baby for its SNOO, a medical device for keeping sleeping babies safely on...

Guide on Dog Infectious Otitis Externa Drugs

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Infectious Otitis Externa Drugs for Topical Use in Dogs.

Deficiencies Found in Ascendis Pharma NDA: FDA

[ Price : $8.95]

FDA finds deficiencies in Ascendis Pharmas NDA for TransCon PTH (palopegteriparatide), indicated for treating hypoparathyroidism.

Draft Guide on AI Device Software Changes

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Marketing Submission Recommendations for a Predetermined Ch...

54% of Confirmatory Studies Are Late Meeting Deadlines

[ Price : $8.95]

A JAMA research letter says 54% of accelerated approval-related confirmatory studies conducted between 2012 and 2021 were late in ...

Accelerated Approval Given to Astellas Padcev

[ Price : $8.95]

FDA approves an Astellas Pharma BLA for Padcev (enfortumab vedotin-ejfv) for use with Mercks Keytruda in certain patients with loc...

FDA Hits India Drug Maker with 14-page 483

[ Price : $8.95]

FDA issues a 14-page Form FDA-483 to Global Pharma Healthcare in Tamilnadu, India that cites significant GMP deficiencies with its...

Bill Would Prevent ANDA Blocking on 1st Generics

[ Price : $8.95]

Senators Tina Smith (D-MN) and Mike Braun (R-IN) reintroduce bipartisan legislation that would prevent brand drug companies from s...

Hutchmed NDA for Colorectal Cancer Drug

[ Price : $8.95]

Hutchmed Ltd. completes a rolling NDA submission for fruquintinib, described as a highly selective and potent oral inhibitor of VE...

Draft Guide Non-IRB Approvable Child Research

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Research Involving Children as Subjects and Not Otherwise A...